MYLENE JAMES: Open Payments
NPI 1184931313 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,440 in 116 payments from 47 companies in 2025. Trend: 2023 $1,190 · 2024 $2,367 · 2025 $3,440
Food & beverage: $3,280Education: $160
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $409 |
| Janssen Biotech, Inc. | 8 | $288 |
| Caris MPI, Inc. | 5 | $260 |
| Merck Sharp & Dohme LLC | 7 | $173 |
| Daiichi Sankyo Inc. | 6 | $154 |
| JAZZ PHARMACEUTICALS INC. | 2 | $134 |
| Eisai Inc. | 2 | $125 |
| Novartis Pharmaceuticals Corporation | 5 | $121 |
| Geron Corporation | 2 | $118 |
| Syndax Pharmaceuticals, Inc. | 2 | $116 |
Products named: MI CANCER SEEK, ENHERTU, KEYTRUDA, ERLEADA, ZEPZELCA, Lenvima, RYTELO, BRUKINSA.
Industry payments across GA — which companies pay providers there.
